Jungbunzlauer Ladenburg Gmbh, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TRISODIUM CITRATE DIHYDRATE, with a corresponding US DMF Number 32842.
Remarkably, this DMF maintains an Active status since its submission on July 12, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2020, and payment made on January 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II